報價延遲最少15分鐘:2024/11/10 17:18 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.568 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-9.70/-2.83
|
|
企業價值
1.98M
|
| 資產負債 |
|
每股賬面淨值
1.77
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
787.00K
|
|
每股收益
0.15
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/11/10 17:18 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. |